Neofenac SR
Generic Name
Diclofenac Sodium Sustained Release
Manufacturer
Square Pharmaceuticals Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
| Variant | Unit Price | Strip Price |
|---|---|---|
| neofenac sr 100 mg capsule | ৳ 3.00 | N/A |
Description
Overview of the medicine
Neofenac SR is a sustained-release formulation of Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID). It is used to relieve pain, swelling, and inflammation in various conditions.
Uses & Indications
Dosage
Adults
Typically 100 mg once daily, preferably with food.
Elderly
Lower effective dose should be used, monitor for adverse effects.
Renal_impairment
Use with caution. Dose reduction may be necessary in severe renal impairment (CrCl <30 mL/min).
How to Take
Take orally with a glass of water, preferably with or after food, to minimize gastrointestinal upset. Do not crush, chew, or break the tablet; swallow it whole.
Mechanism of Action
Diclofenac works by inhibiting the cyclooxygenase (COX) enzymes, COX-1 and COX-2, which are responsible for the synthesis of prostaglandins. Prostaglandins are mediators of pain, inflammation, and fever.
Pharmacokinetics
Onset
Pain relief generally starts within 1-2 hours.
Excretion
Approximately 60% of the dose is excreted in the urine as metabolites, and about 35% is eliminated in the bile and feces.
Half life
Terminal elimination half-life is approximately 1-2 hours for the parent compound, but the sustained-release mechanism extends therapeutic duration.
Absorption
Well absorbed after oral administration. Sustained-release formulation provides prolonged absorption, with peak plasma concentrations occurring 2-4 hours post-dose.
Metabolism
Undergoes extensive first-pass metabolism in the liver, primarily by CYP2C9 to form hydroxylated metabolites.
Side Effects
Contraindications
- •Hypersensitivity to diclofenac or other NSAIDs
- •Active gastrointestinal bleeding or peptic ulcer
- •Severe renal or hepatic failure
- •Severe heart failure
- •Third trimester of pregnancy
- •Coronary artery bypass graft (CABG) surgery
Drug Interactions
Lithium
Increased plasma lithium levels.
Warfarin
Increased risk of bleeding.
Diuretics
Reduced natriuretic effect.
ACE Inhibitors / ARBs
Increased risk of renal impairment.
Storage
Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.
Overdose
Symptoms may include lethargy, drowsiness, nausea, vomiting, epigastric pain, and gastrointestinal bleeding. In rare cases, hypertension, acute renal failure, respiratory depression, and coma may occur. Management is primarily symptomatic and supportive; there is no specific antidote.
Pregnancy & Lactation
Avoid in the third trimester of pregnancy due to risk of premature closure of the ductus arteriosus. Use with caution during early pregnancy and lactation only if clearly needed and benefits outweigh risks. Consult a doctor.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
24 to 36 months from manufacturing date.
Availability
Pharmacies, Hospitals
Approval Status
Approved by DGDA
Patent Status
Off-patent
WHO Essential Medicine
YesAlternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
More Medicines
Explore other medicines you might be interested in
